AustraliaDaily Briefs

Daily Brief Australia: Iress Ltd, National Storage REIT, Intermin Resources, Island Pharmaceuticals , Monadelphous and more

In today’s briefing:

  • Iress (IRE AU): Suitors Engaged, But (Still) Nothing Firm
  • National Storage REIT (NSR AU) In Trading Halt Ahead Of Possible Brookfield/GIC Tilt
  • Horizon Minerals Ltd – Production Update
  • Island Pharmaceuticals Ltd – De-risking the commercial path
  • Primer: Monadelphous (MND AU) – Nov 2025


Iress (IRE AU): Suitors Engaged, But (Still) Nothing Firm

By David Blennerhassett

  • The board of Iress Ltd (IRE AU), a trading and wealth management software provider, has denied reports in an Australian article concerning a possible takeover from Blackstone. 
  • The article said that Blackstone was reportedly back in talks for a bid “that could be worth between $11 and $12 per share“. Iress’ share price promptly popped 8% yesterday. 
  • Iress is still very much in play as it “continues to engage with multiple parties“. 

National Storage REIT (NSR AU) In Trading Halt Ahead Of Possible Brookfield/GIC Tilt

By David Blennerhassett

  • Reportedly, Brookfield and Singapore’s GIC will make an Offer for National Storage REIT (NSR AU), Australia and New Zealand’s largest landlord of self-storage sites .
  • The AFR is reporting that Brookfield/GIC are on the cusp of launching a bid around NTA.  NSR entered into a trading halt this morning. 
  • Earlier this year, key peer Abacus Storage King (ASK AU) fielded an NBIO from Ki Corporation/Public Storage (PSA US) at a ~3% premium to NTA; however, Ki/PSA ultimately walked. 

Horizon Minerals Ltd – Production Update

By RaaS Research Group (RaaS)

  • Horizon Minerals Limited (ASX:HRZ) is an emerging junior gold producer with 1.8moz of gold resources located around the Kalgoorlie and Coolgardie regions of Western Australia.
  • HRZ has announced a production update for both the Boorara and Phillips Find JV mining operations.
  • The update details progression on mining and processing at both projects as well as further detail on forward expectations which we think helps guide investors towards understanding ultimate outcomes.

Island Pharmaceuticals Ltd – De-risking the commercial path

By RaaS Research Group (RaaS)

  • Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
  • The company has made two recent announcements that improve its chances of selling Galidesivir for Marburg to the US government, ahead of potential FDA clearance of the drug.
  • On 20 November 2025 it announced the appointment of leading Washington D.C. based federal government affairs and lobbying firm, Todd Strategy Group (TSG), to support US government engagement.

Primer: Monadelphous (MND AU) – Nov 2025

By αSK

  • Monadelphous is a leading Australian engineering group specializing in construction and maintenance services for the resources, energy, and infrastructure sectors. Its dual-division structure allows it to capture opportunities across the full asset lifecycle.
  • The company is experiencing a period of strong growth, driven by significant contract wins in its core markets, particularly in iron ore and energy. A robust project pipeline and strategic acquisitions are expected to support continued revenue momentum.
  • While exposed to the cyclical nature of the resources sector and persistent skilled labor shortages, Monadelphous‘ strong balance sheet, long-term client relationships with blue-chip companies, and diversification into renewable energy and critical minerals position it to navigate market uncertainties.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars